Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 14 | 2024 | 3805 | 2.020 |
Why?
|
RNA, Small Interfering | 11 | 2019 | 3437 | 1.560 |
Why?
|
Nanoparticles | 12 | 2017 | 1986 | 1.320 |
Why?
|
Islets of Langerhans Transplantation | 10 | 2015 | 748 | 1.220 |
Why?
|
Islets of Langerhans | 12 | 2017 | 1349 | 1.150 |
Why?
|
Doxorubicin | 5 | 2017 | 2229 | 1.130 |
Why?
|
Molecular Imaging | 6 | 2017 | 825 | 1.110 |
Why?
|
Oligonucleotides | 3 | 2020 | 564 | 1.010 |
Why?
|
Carbocyanines | 6 | 2024 | 175 | 0.950 |
Why?
|
Magnetic Resonance Imaging | 26 | 2024 | 36840 | 0.760 |
Why?
|
Ferric Compounds | 5 | 2016 | 379 | 0.740 |
Why?
|
RNA Interference | 5 | 2021 | 2832 | 0.740 |
Why?
|
Magnetite Nanoparticles | 5 | 2019 | 318 | 0.700 |
Why?
|
Diabetes Mellitus, Experimental | 5 | 2017 | 1121 | 0.690 |
Why?
|
Cell Line, Tumor | 21 | 2024 | 17149 | 0.670 |
Why?
|
Pancreas | 5 | 2019 | 1703 | 0.650 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2019 | 123 | 0.630 |
Why?
|
Biosensing Techniques | 2 | 2016 | 663 | 0.620 |
Why?
|
Breast Neoplasms | 13 | 2024 | 21156 | 0.570 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2019 | 647 | 0.540 |
Why?
|
Mucin-1 | 6 | 2016 | 538 | 0.540 |
Why?
|
Drug Carriers | 2 | 2019 | 712 | 0.520 |
Why?
|
Neoplastic Stem Cells | 2 | 2024 | 1357 | 0.520 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2016 | 52 | 0.510 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2013 | 199 | 0.500 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 757 | 0.470 |
Why?
|
Spectroscopy, Near-Infrared | 4 | 2009 | 752 | 0.470 |
Why?
|
Chickens | 3 | 2015 | 860 | 0.460 |
Why?
|
Mice | 45 | 2024 | 82045 | 0.460 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2834 | 0.450 |
Why?
|
Microscopy, Fluorescence | 9 | 2016 | 2640 | 0.440 |
Why?
|
Nanocapsules | 1 | 2014 | 95 | 0.430 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2024 | 3619 | 0.420 |
Why?
|
Cell Movement | 4 | 2024 | 5223 | 0.410 |
Why?
|
Adenocarcinoma | 5 | 2013 | 6400 | 0.390 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2015 | 679 | 0.380 |
Why?
|
Magnetics | 2 | 2012 | 599 | 0.380 |
Why?
|
Animals | 52 | 2024 | 169418 | 0.370 |
Why?
|
Neoplasms, Experimental | 2 | 2014 | 1232 | 0.370 |
Why?
|
Subrenal Capsule Assay | 1 | 2009 | 27 | 0.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2024 | 8635 | 0.330 |
Why?
|
Pancreatic Neoplasms | 4 | 2019 | 5442 | 0.330 |
Why?
|
Oxides | 3 | 2009 | 403 | 0.320 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2010 | 3440 | 0.310 |
Why?
|
Spectrum Analysis, Raman | 1 | 2010 | 244 | 0.310 |
Why?
|
Drug Delivery Systems | 5 | 2017 | 2238 | 0.310 |
Why?
|
Neoplasm Metastasis | 5 | 2024 | 4931 | 0.300 |
Why?
|
Brain Neoplasms | 5 | 2024 | 9182 | 0.290 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1755 | 0.290 |
Why?
|
Disease Models, Animal | 11 | 2024 | 18388 | 0.290 |
Why?
|
Isoantigens | 2 | 2015 | 563 | 0.290 |
Why?
|
Neoplasms | 7 | 2020 | 22386 | 0.290 |
Why?
|
Metal Nanoparticles | 1 | 2012 | 406 | 0.290 |
Why?
|
Iron | 5 | 2014 | 1813 | 0.270 |
Why?
|
Gene Expression | 2 | 2016 | 7605 | 0.260 |
Why?
|
Zinc | 1 | 2010 | 677 | 0.260 |
Why?
|
Apoptosis | 6 | 2019 | 9526 | 0.250 |
Why?
|
Nanostructures | 1 | 2010 | 553 | 0.250 |
Why?
|
Insulin-Secreting Cells | 2 | 2011 | 900 | 0.250 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1078 | 0.240 |
Why?
|
Dextrans | 5 | 2024 | 574 | 0.240 |
Why?
|
Transplantation, Autologous | 1 | 2009 | 2126 | 0.230 |
Why?
|
Cell Proliferation | 5 | 2024 | 10494 | 0.220 |
Why?
|
Eimeria tenella | 1 | 2003 | 3 | 0.220 |
Why?
|
Coccidiosis | 1 | 2003 | 10 | 0.220 |
Why?
|
Poultry Diseases | 1 | 2003 | 26 | 0.220 |
Why?
|
Cecal Diseases | 1 | 2003 | 49 | 0.220 |
Why?
|
Mice, Nude | 6 | 2016 | 3635 | 0.220 |
Why?
|
Peptides | 6 | 2012 | 4368 | 0.210 |
Why?
|
Immunotherapy | 1 | 2019 | 4728 | 0.210 |
Why?
|
Mucins | 1 | 2006 | 570 | 0.210 |
Why?
|
Sarcoma, Avian | 1 | 2002 | 3 | 0.200 |
Why?
|
Microcirculation | 1 | 2007 | 1282 | 0.200 |
Why?
|
Oligonucleotides, Antisense | 3 | 2024 | 462 | 0.200 |
Why?
|
Fluorescence | 3 | 2017 | 760 | 0.190 |
Why?
|
Gene Silencing | 2 | 2010 | 1503 | 0.190 |
Why?
|
Staining and Labeling | 1 | 2006 | 1083 | 0.190 |
Why?
|
Contrast Media | 8 | 2016 | 5336 | 0.190 |
Why?
|
Histocompatibility Antigens | 1 | 2002 | 478 | 0.180 |
Why?
|
Models, Biological | 1 | 2017 | 9505 | 0.180 |
Why?
|
Fluorescent Dyes | 5 | 2017 | 1924 | 0.180 |
Why?
|
Hyperglycemia | 2 | 2008 | 1389 | 0.180 |
Why?
|
Cell Survival | 3 | 2020 | 5801 | 0.170 |
Why?
|
Gadolinium | 3 | 2012 | 965 | 0.170 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2024 | 507 | 0.170 |
Why?
|
Fluorescein-5-isothiocyanate | 2 | 2011 | 222 | 0.170 |
Why?
|
Diagnostic Imaging | 3 | 2009 | 3543 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11843 | 0.160 |
Why?
|
Gadolinium DTPA | 2 | 2012 | 823 | 0.160 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 255 | 0.160 |
Why?
|
Mice, Inbred BALB C | 4 | 2019 | 6241 | 0.160 |
Why?
|
Female | 28 | 2024 | 396943 | 0.150 |
Why?
|
Molecular Probes | 3 | 2009 | 310 | 0.150 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3637 | 0.150 |
Why?
|
Graft Rejection | 4 | 2015 | 4505 | 0.150 |
Why?
|
Humans | 42 | 2024 | 768451 | 0.150 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 720 | 0.140 |
Why?
|
Liver Transplantation | 1 | 2009 | 2399 | 0.140 |
Why?
|
Flow Cytometry | 3 | 2014 | 5904 | 0.140 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 890 | 0.130 |
Why?
|
Avian Proteins | 1 | 2015 | 79 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2010 | 4642 | 0.120 |
Why?
|
Indocyanine Green | 1 | 2017 | 239 | 0.120 |
Why?
|
Glioblastoma | 2 | 2024 | 3523 | 0.120 |
Why?
|
Deoxycytidine | 1 | 2019 | 888 | 0.120 |
Why?
|
Luminescent Measurements | 1 | 2016 | 342 | 0.110 |
Why?
|
Nanomedicine | 1 | 2017 | 291 | 0.110 |
Why?
|
Infrared Rays | 2 | 2005 | 249 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1339 | 0.110 |
Why?
|
Base Pairing | 1 | 2014 | 139 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13708 | 0.110 |
Why?
|
Mice, Inbred NOD | 5 | 2012 | 1839 | 0.110 |
Why?
|
Cell-Free System | 1 | 2014 | 340 | 0.110 |
Why?
|
Ribonucleases | 1 | 2014 | 266 | 0.110 |
Why?
|
Drug Monitoring | 1 | 2019 | 964 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2009 | 9066 | 0.100 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 808 | 0.100 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6135 | 0.100 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6657 | 0.100 |
Why?
|
Streptozocin | 2 | 2015 | 195 | 0.100 |
Why?
|
Dacarbazine | 1 | 2014 | 560 | 0.100 |
Why?
|
Chelating Agents | 2 | 2010 | 385 | 0.090 |
Why?
|
Biological Availability | 1 | 2012 | 390 | 0.090 |
Why?
|
Sphingomyelins | 1 | 2011 | 105 | 0.090 |
Why?
|
Salts | 1 | 2010 | 62 | 0.090 |
Why?
|
Ferrosoferric Oxide | 2 | 2009 | 349 | 0.090 |
Why?
|
Blotting, Western | 3 | 2012 | 5042 | 0.090 |
Why?
|
Mice, Transgenic | 3 | 2016 | 9558 | 0.090 |
Why?
|
DNA Repair | 1 | 2020 | 2051 | 0.090 |
Why?
|
Drug Stability | 1 | 2010 | 291 | 0.090 |
Why?
|
Fluorine Compounds | 1 | 2009 | 7 | 0.090 |
Why?
|
Transfection | 2 | 2016 | 5767 | 0.090 |
Why?
|
Particle Size | 1 | 2014 | 1654 | 0.080 |
Why?
|
Fibrin | 1 | 2012 | 515 | 0.080 |
Why?
|
Major Histocompatibility Complex | 3 | 2012 | 877 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1909 | 0.080 |
Why?
|
Drug Design | 1 | 2014 | 1050 | 0.080 |
Why?
|
Curcumin | 1 | 2009 | 98 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2015 | 3080 | 0.080 |
Why?
|
Image Enhancement | 2 | 2010 | 2894 | 0.080 |
Why?
|
Mice, SCID | 3 | 2012 | 2633 | 0.070 |
Why?
|
Boron Compounds | 1 | 2009 | 196 | 0.070 |
Why?
|
Surface Properties | 1 | 2010 | 1168 | 0.070 |
Why?
|
Computational Biology | 1 | 2020 | 3546 | 0.070 |
Why?
|
Lymphatic Metastasis | 2 | 2012 | 2930 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11206 | 0.070 |
Why?
|
Papio | 1 | 2009 | 671 | 0.070 |
Why?
|
Pentetic Acid | 1 | 2007 | 209 | 0.070 |
Why?
|
Cell Cycle | 1 | 2015 | 2942 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2012 | 22365 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6978 | 0.070 |
Why?
|
Gold | 1 | 2010 | 489 | 0.070 |
Why?
|
Lymphocytes | 2 | 2015 | 2611 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1608 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3939 | 0.060 |
Why?
|
Antigens | 1 | 2011 | 1443 | 0.060 |
Why?
|
Molecular Probe Techniques | 1 | 2006 | 111 | 0.060 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 934 | 0.060 |
Why?
|
Annexin A5 | 1 | 2005 | 104 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2944 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2012 | 1092 | 0.060 |
Why?
|
Cattle | 1 | 2010 | 3830 | 0.060 |
Why?
|
Cyclohexanes | 1 | 2005 | 152 | 0.060 |
Why?
|
Transplantation, Heterologous | 2 | 2012 | 2393 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5342 | 0.060 |
Why?
|
Pancreatectomy | 1 | 2009 | 824 | 0.060 |
Why?
|
Optics and Photonics | 1 | 2006 | 307 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11249 | 0.060 |
Why?
|
Liposomes | 1 | 2008 | 792 | 0.060 |
Why?
|
Breast | 1 | 2012 | 1976 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13452 | 0.050 |
Why?
|
Disease Progression | 2 | 2012 | 13655 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2010 | 1375 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 2072 | 0.050 |
Why?
|
Coloring Agents | 1 | 2005 | 564 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2009 | 1434 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 17647 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5909 | 0.050 |
Why?
|
Environmental Monitoring | 1 | 2009 | 1464 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2126 | 0.050 |
Why?
|
Autoimmunity | 1 | 2010 | 1361 | 0.050 |
Why?
|
Angiography | 1 | 2007 | 1598 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11138 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8559 | 0.050 |
Why?
|
Fluorouracil | 1 | 2006 | 1656 | 0.050 |
Why?
|
Microscopy, Confocal | 4 | 2008 | 1977 | 0.040 |
Why?
|
Water | 1 | 2005 | 1421 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2005 | 1034 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2731 | 0.040 |
Why?
|
Antibodies, Monoclonal | 3 | 2011 | 9263 | 0.040 |
Why?
|
Rats | 2 | 2011 | 23839 | 0.040 |
Why?
|
Pyridines | 1 | 2010 | 2888 | 0.040 |
Why?
|
Insulin | 2 | 2011 | 6606 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 2003 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2017 | 2298 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20231 | 0.040 |
Why?
|
Blood Glucose | 2 | 2015 | 6429 | 0.040 |
Why?
|
Graft Survival | 1 | 2008 | 3890 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16712 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2260 | 0.030 |
Why?
|
Indoles | 1 | 2005 | 1834 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1797 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2010 | 3108 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2009 | 3891 | 0.030 |
Why?
|
Glycosylation | 2 | 2012 | 1100 | 0.030 |
Why?
|
Papio hamadryas | 1 | 2015 | 32 | 0.030 |
Why?
|
Early Detection of Cancer | 1 | 2010 | 3230 | 0.030 |
Why?
|
Haplotypes | 1 | 2002 | 2725 | 0.030 |
Why?
|
Scorpion Venoms | 1 | 2014 | 30 | 0.030 |
Why?
|
Glioma | 1 | 2010 | 3523 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4586 | 0.030 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2014 | 83 | 0.030 |
Why?
|
Kidney | 1 | 2009 | 7064 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2016 | 65409 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5152 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2009 | 12242 | 0.030 |
Why?
|
Molecular Structure | 2 | 2009 | 1889 | 0.030 |
Why?
|
Weight Gain | 1 | 2003 | 2357 | 0.030 |
Why?
|
Sialyltransferases | 1 | 2012 | 83 | 0.030 |
Why?
|
Neuraminidase | 1 | 2012 | 195 | 0.030 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2012 | 175 | 0.020 |
Why?
|
Fumonisins | 1 | 2011 | 10 | 0.020 |
Why?
|
Chromatography | 1 | 2011 | 189 | 0.020 |
Why?
|
Toxins, Biological | 1 | 2011 | 60 | 0.020 |
Why?
|
beta-Cyclodextrins | 1 | 2011 | 67 | 0.020 |
Why?
|
Cell Line | 3 | 2011 | 15609 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3816 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2012 | 551 | 0.020 |
Why?
|
Neurons | 1 | 2010 | 9504 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11930 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 2010 | 71 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2268 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 5887 | 0.020 |
Why?
|
Perforin | 1 | 2010 | 169 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2012 | 1706 | 0.020 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 117 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2010 | 281 | 0.020 |
Why?
|
Genotype | 1 | 2003 | 13047 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14728 | 0.020 |
Why?
|
Caspase 3 | 1 | 2011 | 732 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2010 | 574 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1196 | 0.020 |
Why?
|
Prognosis | 2 | 2012 | 30028 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4834 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2422 | 0.020 |
Why?
|
Male | 4 | 2016 | 364781 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2006 | 699 | 0.020 |
Why?
|
beta-Alanine | 1 | 2005 | 82 | 0.020 |
Why?
|
Acute Disease | 1 | 2015 | 7246 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1969 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2010 | 1251 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2005 | 475 | 0.010 |
Why?
|
Solubility | 1 | 2005 | 1086 | 0.010 |
Why?
|
Brain | 1 | 2010 | 27438 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2005 | 694 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4213 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2565 | 0.010 |
Why?
|
Astrocytes | 1 | 2010 | 1354 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2005 | 1543 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3169 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5308 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2434 | 0.010 |
Why?
|
Polymers | 1 | 2008 | 1631 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3734 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3346 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2002 | 18048 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40271 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12428 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9376 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15460 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12875 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12813 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1818 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3586 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2005 | 2528 | 0.010 |
Why?
|
Proteins | 1 | 2010 | 6008 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 19041 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 11674 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39430 | 0.010 |
Why?
|